Genomic Health Inc. (GHDX)

[mlkrborn]

8:03AM Genomic Health announces presentation of two Oncotype DX Studies; New findings reinforce value of Oncotype DX (GHDX) 31.94 : Co reports that new findings reinforce value of Oncotype DX in node-positive breast cancer patients; separate presentation provides background on development of DCIS Score. "These results add to a large body of evidence, now totaling more than 2,000 patients, demonstrating that the Recurrence Score provides independent distant recurrence risk information that provides value beyond clinical and pathologic factors in node-positive disease," said Steven Shak, M.D., chief medical officer at Genomic Health. "Across multiple studies, we observe consistent support for the use of Oncotype DX as a useful tool to guide treatment decisions for early-stage breast cancer patients, including those with node-positive disease."